“Revolutionizing Cancer Treatment: Hyundai ADM Introduces Groundbreaking Continuous Oral Chemotherapy with Reduced Side Effects and Risks – Preclinical Study Shows Promise”
Welcome to the Future of Cancer Treatment Hyundai ADM Bio Unveils Groundbreaking Oral Anti-Cancer Drug at Biotech Showcase 2025 SEOUL, South Korea, Jan. 22, 2025 /PRNewswire/ — Hyundai ADM Bio (Co-CEOs Taek-Sung Kim and Kwang-Hee Kim) announced the results of its preclinical study on the oral anti-cancer drug OTX-M, developed from the well-known injectable chemotherapy…